The Market Reports

Index

1 Metoclopramide Market Overview
1.1 Product Overview and Scope of Metoclopramide
1.2 Metoclopramide Segment by Type
1.2.1 Global Metoclopramide Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Oral
1.2.3 Injection
1.3 Metoclopramide Segment by Application
1.3.1 Metoclopramide Sales Comparison by Application: (2021-2027)
1.3.2 Nausea
1.3.3 Migraine
1.3.4 Gastroparesis
1.4 Global Metoclopramide Market Size Estimates and Forecasts
1.4.1 Global Metoclopramide Revenue 2016-2027
1.4.2 Global Metoclopramide Sales 2016-2027
1.4.3 Metoclopramide Market Size by Region: 2016 Versus 2021 Versus 2027

2 Metoclopramide Market Competition by Manufacturers
2.1 Global Metoclopramide Sales Market Share by Manufacturers (2016-2021)
2.2 Global Metoclopramide Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Metoclopramide Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Metoclopramide Manufacturing Sites, Area Served, Product Type
2.5 Metoclopramide Market Competitive Situation and Trends
2.5.1 Metoclopramide Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Metoclopramide Players Market Share by Revenue
2.5.3 Global Metoclopramide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Metoclopramide Retrospective Market Scenario by Region
3.1 Global Metoclopramide Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Metoclopramide Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Metoclopramide Market Facts & Figures by Country
3.3.1 North America Metoclopramide Sales by Country
3.3.2 North America Metoclopramide Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Metoclopramide Market Facts & Figures by Country
3.4.1 Europe Metoclopramide Sales by Country
3.4.2 Europe Metoclopramide Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Metoclopramide Market Facts & Figures by Region
3.5.1 Asia Pacific Metoclopramide Sales by Region
3.5.2 Asia Pacific Metoclopramide Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Metoclopramide Market Facts & Figures by Country
3.6.1 Latin America Metoclopramide Sales by Country
3.6.2 Latin America Metoclopramide Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Metoclopramide Market Facts & Figures by Country
3.7.1 Middle East and Africa Metoclopramide Sales by Country
3.7.2 Middle East and Africa Metoclopramide Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Metoclopramide Historic Market Analysis by Type
4.1 Global Metoclopramide Sales Market Share by Type (2016-2021)
4.2 Global Metoclopramide Revenue Market Share by Type (2016-2021)
4.3 Global Metoclopramide Price by Type (2016-2021)

5 Global Metoclopramide Historic Market Analysis by Application
5.1 Global Metoclopramide Sales Market Share by Application (2016-2021)
5.2 Global Metoclopramide Revenue Market Share by Application (2016-2021)
5.3 Global Metoclopramide Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Teva Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sanofi Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Astellas
6.3.1 Astellas Corporation Information
6.3.2 Astellas Description and Business Overview
6.3.3 Astellas Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Astellas Product Portfolio
6.3.5 Astellas Recent Developments/Updates
6.4 Adwya
6.4.1 Adwya Corporation Information
6.4.2 Adwya Description and Business Overview
6.4.3 Adwya Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Adwya Product Portfolio
6.4.5 Adwya Recent Developments/Updates
6.5 Biofarma
6.5.1 Biofarma Corporation Information
6.5.2 Biofarma Description and Business Overview
6.5.3 Biofarma Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Biofarma Product Portfolio
6.5.5 Biofarma Recent Developments/Updates
6.6 Apotex
6.6.1 Apotex Corporation Information
6.6.2 Apotex Description and Business Overview
6.6.3 Apotex Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Apotex Product Portfolio
6.6.5 Apotex Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Novartis Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 ASKA Seiyaku Asuka
6.8.1 ASKA Seiyaku Asuka Corporation Information
6.8.2 ASKA Seiyaku Asuka Description and Business Overview
6.8.3 ASKA Seiyaku Asuka Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.8.4 ASKA Seiyaku Asuka Product Portfolio
6.8.5 ASKA Seiyaku Asuka Recent Developments/Updates
6.9 Yang Sheng
6.9.1 Yang Sheng Corporation Information
6.9.2 Yang Sheng Description and Business Overview
6.9.3 Yang Sheng Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Yang Sheng Product Portfolio
6.9.5 Yang Sheng Recent Developments/Updates
6.10 Meda Pharma
6.10.1 Meda Pharma Corporation Information
6.10.2 Meda Pharma Description and Business Overview
6.10.3 Meda Pharma Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Meda Pharma Product Portfolio
6.10.5 Meda Pharma Recent Developments/Updates
6.11 Johnson and Johnson
6.11.1 Johnson and Johnson Corporation Information
6.11.2 Johnson and Johnson Metoclopramide Description and Business Overview
6.11.3 Johnson and Johnson Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Johnson and Johnson Product Portfolio
6.11.5 Johnson and Johnson Recent Developments/Updates
6.12 GSK
6.12.1 GSK Corporation Information
6.12.2 GSK Metoclopramide Description and Business Overview
6.12.3 GSK Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.12.4 GSK Product Portfolio
6.12.5 GSK Recent Developments/Updates
6.13 Alkaloid Pharmaceuticals
6.13.1 Alkaloid Pharmaceuticals Corporation Information
6.13.2 Alkaloid Pharmaceuticals Metoclopramide Description and Business Overview
6.13.3 Alkaloid Pharmaceuticals Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Alkaloid Pharmaceuticals Product Portfolio
6.13.5 Alkaloid Pharmaceuticals Recent Developments/Updates
6.14 Teuto Brasileiro
6.14.1 Teuto Brasileiro Corporation Information
6.14.2 Teuto Brasileiro Metoclopramide Description and Business Overview
6.14.3 Teuto Brasileiro Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Teuto Brasileiro Product Portfolio
6.14.5 Teuto Brasileiro Recent Developments/Updates
6.15 Mylan
6.15.1 Mylan Corporation Information
6.15.2 Mylan Metoclopramide Description and Business Overview
6.15.3 Mylan Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Mylan Product Portfolio
6.15.5 Mylan Recent Developments/Updates
6.16 EU-Pharma
6.16.1 EU-Pharma Corporation Information
6.16.2 EU-Pharma Metoclopramide Description and Business Overview
6.16.3 EU-Pharma Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.16.4 EU-Pharma Product Portfolio
6.16.5 EU-Pharma Recent Developments/Updates
6.17 Le Vet
6.17.1 Le Vet Corporation Information
6.17.2 Le Vet Metoclopramide Description and Business Overview
6.17.3 Le Vet Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Le Vet Product Portfolio
6.17.5 Le Vet Recent Developments/Updates
6.18 Omega Laboratories
6.18.1 Omega Laboratories Corporation Information
6.18.2 Omega Laboratories Metoclopramide Description and Business Overview
6.18.3 Omega Laboratories Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Omega Laboratories Product Portfolio
6.18.5 Omega Laboratories Recent Developments/Updates
6.19 Orion Pharma
6.19.1 Orion Pharma Corporation Information
6.19.2 Orion Pharma Metoclopramide Description and Business Overview
6.19.3 Orion Pharma Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Orion Pharma Product Portfolio
6.19.5 Orion Pharma Recent Developments/Updates
6.20 Pfizer
6.20.1 Pfizer Corporation Information
6.20.2 Pfizer Metoclopramide Description and Business Overview
6.20.3 Pfizer Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Pfizer Product Portfolio
6.20.5 Pfizer Recent Developments/Updates
6.21 Wockhardt
6.21.1 Wockhardt Corporation Information
6.21.2 Wockhardt Metoclopramide Description and Business Overview
6.21.3 Wockhardt Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Wockhardt Product Portfolio
6.21.5 Wockhardt Recent Developments/Updates
6.22 Amneal Pharmaceuticals
6.22.1 Amneal Pharmaceuticals Corporation Information
6.22.2 Amneal Pharmaceuticals Metoclopramide Description and Business Overview
6.22.3 Amneal Pharmaceuticals Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.22.4 Amneal Pharmaceuticals Product Portfolio
6.22.5 Amneal Pharmaceuticals Recent Developments/Updates
6.23 Nidda
6.23.1 Nidda Corporation Information
6.23.2 Nidda Metoclopramide Description and Business Overview
6.23.3 Nidda Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.23.4 Nidda Product Portfolio
6.23.5 Nidda Recent Developments/Updates
6.24 Ceva Sante Animale
6.24.1 Ceva Sante Animale Corporation Information
6.24.2 Ceva Sante Animale Metoclopramide Description and Business Overview
6.24.3 Ceva Sante Animale Metoclopramide Sales, Revenue and Gross Margin (2016-2021)
6.24.4 Ceva Sante Animale Product Portfolio
6.24.5 Ceva Sante Animale Recent Developments/Updates

7 Metoclopramide Manufacturing Cost Analysis
7.1 Metoclopramide Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Metoclopramide
7.4 Metoclopramide Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Metoclopramide Distributors List
8.3 Metoclopramide Customers

9 Metoclopramide Market Dynamics
9.1 Metoclopramide Industry Trends
9.2 Metoclopramide Growth Drivers
9.3 Metoclopramide Market Challenges
9.4 Metoclopramide Market Restraints

10 Global Market Forecast
10.1 Metoclopramide Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Metoclopramide by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Metoclopramide by Type (2022-2027)
10.2 Metoclopramide Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Metoclopramide by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Metoclopramide by Application (2022-2027)
10.3 Metoclopramide Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Metoclopramide by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Metoclopramide by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Metoclopramide Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Metoclopramide Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Metoclopramide Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Metoclopramide Covered in This Study
Table 5. Global Metoclopramide Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Metoclopramide Sales Share by Manufacturers (2016-2021)
Table 7. Global Metoclopramide Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Metoclopramide Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Metoclopramide Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Metoclopramide Manufacturing Sites and Area Served
Table 11. Manufacturers Metoclopramide Product Type
Table 12. Global Metoclopramide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Metoclopramide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metoclopramide as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Metoclopramide Sales by Region (2016-2021) & (K Units)
Table 16. Global Metoclopramide Sales Market Share by Region (2016-2021)
Table 17. Global Metoclopramide Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Metoclopramide Sales by Country (2016-2021) & (K Units)
Table 19. North America Metoclopramide Sales Market Share by Country (2016-2021)
Table 20. North America Metoclopramide Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Metoclopramide Revenue Market Share by Country (2016-2021)
Table 22. Europe Metoclopramide Sales by Country (2016-2021) & (K Units)
Table 23. Europe Metoclopramide Sales Market Share by Country (2016-2021)
Table 24. Europe Metoclopramide Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Metoclopramide Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Metoclopramide Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Metoclopramide Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Metoclopramide Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Metoclopramide Revenue Market Share by Region (2016-2021)
Table 30. Latin America Metoclopramide Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Metoclopramide Sales Market Share by Country (2016-2021)
Table 32. Latin America Metoclopramide Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Metoclopramide Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Metoclopramide Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Metoclopramide Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Metoclopramide Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Metoclopramide Revenue Market Share by Country (2016-2021)
Table 38. Global Metoclopramide Sales (K Units) by Type (2016-2021)
Table 39. Global Metoclopramide Sales Market Share by Type (2016-2021)
Table 40. Global Metoclopramide Revenue (Million US$) by Type (2016-2021)
Table 41. Global Metoclopramide Revenue Share by Type (2016-2021)
Table 42. Global Metoclopramide Price (US$/Unit) by Type (2016-2021)
Table 43. Global Metoclopramide Sales (K Units) by Application (2016-2021)
Table 44. Global Metoclopramide Sales Market Share by Application (2016-2021)
Table 45. Global Metoclopramide Revenue (Million US$) by Application (2016-2021)
Table 46. Global Metoclopramide Revenue Share by Application (2016-2021)
Table 47. Global Metoclopramide Price (US$/Unit) by Application (2016-2021)
Table 48. Teva Corporation Information
Table 49. Teva Description and Business Overview
Table 50. Teva Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Teva Metoclopramide Product
Table 52. Teva Recent Developments/Updates
Table 53. Sanofi Corporation Information
Table 54. Sanofi Description and Business Overview
Table 55. Sanofi Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Sanofi Metoclopramide Product
Table 57. Sanofi Recent Developments/Updates
Table 58. Astellas Corporation Information
Table 59. Astellas Description and Business Overview
Table 60. Astellas Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Astellas Metoclopramide Product
Table 62. Astellas Recent Developments/Updates
Table 63. Adwya Corporation Information
Table 64. Adwya Description and Business Overview
Table 65. Adwya Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Adwya Metoclopramide Product
Table 67. Adwya Recent Developments/Updates
Table 68. Biofarma Corporation Information
Table 69. Biofarma Description and Business Overview
Table 70. Biofarma Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Biofarma Metoclopramide Product
Table 72. Biofarma Recent Developments/Updates
Table 73. Apotex Corporation Information
Table 74. Apotex Description and Business Overview
Table 75. Apotex Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Apotex Metoclopramide Product
Table 77. Apotex Recent Developments/Updates
Table 78. Novartis Corporation Information
Table 79. Novartis Description and Business Overview
Table 80. Novartis Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Novartis Metoclopramide Product
Table 82. Novartis Recent Developments/Updates
Table 83. ASKA Seiyaku Asuka Corporation Information
Table 84. ASKA Seiyaku Asuka Description and Business Overview
Table 85. ASKA Seiyaku Asuka Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. ASKA Seiyaku Asuka Metoclopramide Product
Table 87. ASKA Seiyaku Asuka Recent Developments/Updates
Table 88. Yang Sheng Corporation Information
Table 89. Yang Sheng Description and Business Overview
Table 90. Yang Sheng Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Yang Sheng Metoclopramide Product
Table 92. Yang Sheng Recent Developments/Updates
Table 93. Meda Pharma Corporation Information
Table 94. Meda Pharma Description and Business Overview
Table 95. Meda Pharma Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Meda Pharma Metoclopramide Product
Table 97. Meda Pharma Recent Developments/Updates
Table 98. Johnson and Johnson Corporation Information
Table 99. Johnson and Johnson Description and Business Overview
Table 100. Johnson and Johnson Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Johnson and Johnson Metoclopramide Product
Table 102. Johnson and Johnson Recent Developments/Updates
Table 103. GSK Corporation Information
Table 104. GSK Description and Business Overview
Table 105. GSK Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. GSK Metoclopramide Product
Table 107. GSK Recent Developments/Updates
Table 108. Alkaloid Pharmaceuticals Corporation Information
Table 109. Alkaloid Pharmaceuticals Description and Business Overview
Table 110. Alkaloid Pharmaceuticals Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Alkaloid Pharmaceuticals Metoclopramide Product
Table 112. Alkaloid Pharmaceuticals Recent Developments/Updates
Table 113. Teuto Brasileiro Corporation Information
Table 114. Teuto Brasileiro Description and Business Overview
Table 115. Teuto Brasileiro Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Teuto Brasileiro Metoclopramide Product
Table 117. Teuto Brasileiro Recent Developments/Updates
Table 118. Mylan Corporation Information
Table 119. Mylan Description and Business Overview
Table 120. Mylan Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Mylan Metoclopramide Product
Table 122. Mylan Recent Developments/Updates
Table 123. EU-Pharma Corporation Information
Table 124. EU-Pharma Description and Business Overview
Table 125. EU-Pharma Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. EU-Pharma Metoclopramide Product
Table 127. EU-Pharma Recent Developments/Updates
Table 128. Le Vet Corporation Information
Table 129. Le Vet Description and Business Overview
Table 130. Le Vet Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Le Vet Metoclopramide Product
Table 132. Le Vet Recent Developments/Updates
Table 133. Omega Laboratories Corporation Information
Table 134. Omega Laboratories Description and Business Overview
Table 135. Omega Laboratories Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Omega Laboratories Metoclopramide Product
Table 137. Omega Laboratories Recent Developments/Updates
Table 138. Orion Pharma Corporation Information
Table 139. Orion Pharma Description and Business Overview
Table 140. Orion Pharma Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. Orion Pharma Metoclopramide Product
Table 142. Orion Pharma Recent Developments/Updates
Table 143. Pfizer Corporation Information
Table 144. Pfizer Description and Business Overview
Table 145. Pfizer Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 146. Pfizer Metoclopramide Product
Table 147. Pfizer Recent Developments/Updates
Table 148. Wockhardt Corporation Information
Table 149. Wockhardt Description and Business Overview
Table 150. Wockhardt Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 151. Wockhardt Metoclopramide Product
Table 152. Wockhardt Recent Developments/Updates
Table 153. Amneal Pharmaceuticals Corporation Information
Table 154. Amneal Pharmaceuticals Description and Business Overview
Table 155. Amneal Pharmaceuticals Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 156. Amneal Pharmaceuticals Metoclopramide Product
Table 157. Amneal Pharmaceuticals Recent Developments/Updates
Table 158. Nidda Corporation Information
Table 159. Nidda Description and Business Overview
Table 160. Nidda Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 161. Nidda Metoclopramide Product
Table 162. Nidda Recent Developments/Updates
Table 163. Ceva Sante Animale Corporation Information
Table 164. Ceva Sante Animale Description and Business Overview
Table 165. Ceva Sante Animale Metoclopramide Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 166. Ceva Sante Animale Metoclopramide Product
Table 167. Ceva Sante Animale Recent Developments/Updates
Table 168. Production Base and Market Concentration Rate of Raw Material
Table 169. Key Suppliers of Raw Materials
Table 170. Metoclopramide Distributors List
Table 171. Metoclopramide Customers List
Table 172. Metoclopramide Market Trends
Table 173. Metoclopramide Growth Drivers
Table 174. Metoclopramide Market Restraints
Table 175. Global Metoclopramide Sales Forecast by Type (2022-2027) & (K Units)
Table 176. Global Metoclopramide Sales Market Share Forecast by Type (2022-2027)
Table 177. Global Metoclopramide Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 178. Global Metoclopramide Revenue Market Share Forecast by Type (2022-2027)
Table 179. Global Metoclopramide Sales Forecast by Application (2022-2027) & (K Units)
Table 180. Global Metoclopramide Sales Market Share Forecast by Application (2022-2027)
Table 181. Global Metoclopramide Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 182. Global Metoclopramide Revenue Market Share Forecast by Application (2022-2027)
Table 183. Global Metoclopramide Sales Forecast by Region (2022-2027) & (K Units)
Table 184. Global Metoclopramide Sales Market Share Forecast by Region (2022-2027)
Table 185. Global Metoclopramide Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 186. Global Metoclopramide Revenue Market Share Forecast by Region (2022-2027)
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Metoclopramide
Figure 2. Global Metoclopramide Market Share by Type in 2020 & 2027
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. Global Metoclopramide Market Share by Application in 2020 & 2027
Figure 6. Nausea
Figure 7. Migraine
Figure 8. Gastroparesis
Figure 9. Global Metoclopramide Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Metoclopramide Market Size 2016-2027 (US$ Million)
Figure 11. Global Metoclopramide Sales 2016-2027 (K Units)
Figure 12. Global Metoclopramide Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Metoclopramide Sales Share by Manufacturers in 2020
Figure 14. Global Metoclopramide Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Metoclopramide Players: Market Share by Revenue in 2020
Figure 16. Metoclopramide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Metoclopramide Sales Market Share by Region (2016-2021)
Figure 18. Global Metoclopramide Sales Market Share by Region in 2020
Figure 19. Global Metoclopramide Revenue Market Share by Region (2016-2021)
Figure 20. Global Metoclopramide Revenue Market Share by Region in 2020
Figure 21. U.S. Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Metoclopramide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Metoclopramide by Type (2016-2021)
Figure 46. Sales Market Share of Metoclopramide by Application (2016-2021)
Figure 47. Sales Market Share of Metoclopramide by Application in 2020
Figure 48. Revenue Share of Metoclopramide by Application (2016-2021)
Figure 49. Revenue Share of Metoclopramide by Application in 2020
Figure 50. Manufacturing Cost Structure of Metoclopramide
Figure 51. Manufacturing Process Analysis of Metoclopramide
Figure 52. Metoclopramide Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed